Transcript frequently asked questions - Know Pain Educational Program

FREQUENTLY ASKED QUESTIONS
Frequently Asked Questions
• How can patients with central sensitization/
dysfunctional pain syndromes be identified?
• When should fibromyalgia be suspected?
• How can patients with fibromyalgia be identified?
• What is “fibro fog”?
• What characterizes the sleep problems in fibromyalgia?
• What kind of exercise should be recommended to
fibromyalgia patients?
• What are the treatment implications of the
pathophysiological changes seen in fibromyalgia patients?
• When should patients suffering from central sensitization/
dysfunctional pain syndromes be referred to a specialist?
How can patients with central sensitization/
dysfunctional pain syndromes be identified?
Clinical Features of Central Sensitization/Dysfunctional Pain
Pain
•
•
•
•
•
•
Pain all over body
Muscles stiff/achy
Headaches
Pain in jaw
Pelvic pain
Bladder/urination pain
Anxiety/depression
•
•
•
•
•
Fatigue
• Do not sleep well
• Unrefreshed in morning
• Easily tired with physical activity
Mayer TG et al. Pain Pract 2012; 12(4):276-85.
Sad or depressed
Anxiety
Stress makes symptoms worse
Tension in neck and shoulder
Grind/clench teeth
Other symptoms
•
•
•
•
•
Difficulty concentrating
Need help with daily activities
Sensitive to bright lights
Skin problems
Diarrhea/constipation
Central Sensitization Inventory (CSI)
• A self-report measure designed to assess key somatic
and emotional symptoms often associated with central
sensitivity syndromes, including fibromyalgia
• Clinical goal: help better assess symptoms to aid
physicians in syndrome categorization, sensitivity,
severity, identification, and treatment planning and to
help minimize or avoid unnecessary diagnostics and
treatment procedures
• Fibromyalgia patients report high CSI scores
• Test demonstrates psychometric strength,
clinical utility and validity
Mayer TG et al. Pain Pract 2012; 12(4):276-85.
When should fibromyalgia
be suspected?
• This is a pain drawing
– Patient colors all areas of
the body in which he or
she feels pain1
• The diagram shows that
the pain of fibromyalgia
is widespread2
Back
Front
Adapted from pain drawing provided courtesy of L Bateman.
1. Silverman SL, Martin SA. In: Wallace DJ, Clauws DJ (eds.). Fibromyalgia & Other Central Pain Syndromes.
Lippincott, Williams & Wilkins; Philadelphia, PA: 2005; 2. Wolfe F et al. Arthritis Rheum 1990; 33(2):160-72.
Core Clinical Features of Fibromyalgia
Widespread pain
• Chronic, widespread
pain
is the defining
Widespread
Pain
feature of fibromyalgia
• Chronic, widespread pain
is the defining feature
• ofPatient
fibromyalgiadescriptors
of
paindescriptors
include:
• Patient
of pain include:
aching, exhausting, nagging, and
hurting• Aching
• Presence of tender points
• Exhausting
Neurocognitive impairment
(“fibro fog”)
Sleep disturbance/fatigue
Mood disorders
• Nagging
• Hurting
Morning stiffness
Carruthers BM et al. J Chron Fat Synd 2003; 11(1):7-115; Harding SM. Am J Med Sci 1998; 315(6):367-37; Henriksson. J Rehabil Med 2003; 41(41 Suppl):89-94; Leavitt et
al. Arthritis Rheum 1986; 29(6):775-81; Roizenblatt S et al. Arthritis Rheum 2001; 44(1):222-30; Wolfe F et al Arthritis Rheum 1990; 33(2):160-72; Wolfe F et al. Arthritis
Rheum 1995; 38(1):19-28.
How can patients with fibromyalgia
be identified?
Items
FiRST: Fibromyalgia Rapid
Screening Tool
• Self-administered 6-item
questionnaire
• Score of ≥5 is indicative
of fibromyalgia
• Sensitivity: 90.5%
• Specificity: 85.7%
Perrot S et al. Pain 2010; 150(2):250-6.
1. I have pain all over my body.
2. My pain is accompanied by continuous and very
unpleasant general fatigue.
3. My pain feels like burns, electric shocks
or cramps.
4. My pain is accompanied by other unusual
sensations throughout my body, such as pins
and needles, tingling or numbness.
5. My pain is accompanied by other health
problems such as digestive problems, urinary
problems, headaches or restless legs.
6. My pain has a significant impact on my life,
particularly on my sleep and my ability to
concentrate, making me feel slower generally.
What is “fibro fog”?
• Compared to those without the
condition, patients with
fibromyalgia complain more often
of:1
– Mental confusion
– Memory decline
– Speech difficulty
• Performance on cognitive tests
shows they have poorer
performance than age-matched
controls on tasks involving:2
– Working memory
– Recognition memory
– Free recall
– Verbal fluency
– Verbal knowledge
1. Katz RS et al. J Clin Rheumatol 2004; 10(2):53-8; 2.Park DC et al. Arthritis Rheum 2001; 44(9):2125-33.
What characterizes the sleep problems
in fibromyalgia?
• Fibromyalgia patients may complain of:
– Non-restorative sleep
– Insomnia
– Early morning awakening
– Poor sleep quality
Bradley LA. Am J Med 2009; 122(12 Suppl):S22-30.
What kind of exercise should be
recommended to fibromyalgia patients?
Type of Exercise
• Try to include different types in one session
(e.g., aerobic, strengthening, stretching)
• Patient preference and availability should
guide selection
Intensity
• Start low, go slow
• Gradually increase to reach moderate intensity
level
10
Busch AJ et al. Curr Pain Headache Rep 2011; 15(5):358-67.
What are the treatment implications of the pathophysiological
changes seen in fibromyalgia patients?
• Mechanisms of action of certain medications
may be related to proposed
fibromyalgia pathophysiologies
• Understanding of fibromyalgia is evolving
• However, reproducible central nervous system
biomarkers underlying fibromyalgia have not
been realized
• Base treatment on proven clinical efficacy
• Treatment should be individualized to the patient
El-Gabalawy H, Ryner L. J Rheumatol. 2008; 35(7):1242-4; Recla JM. J Pain Res 2010; 3: 89-103.
When should patients with fibromyalgia or suspected
fibromyalgia be referred to a specialist?
• Specialist consultation recommended
for patients:
– With atypical symptoms that might suggest an
alternate diagnosis
– Who have failed management in primary care
– Who have complex comorbidities
– For whom sleep evaluation or psychological
consultation is indicated
Fitzcharles MA et al. Pain Res Manag 2013; 18(3):119-26.